Hematologic Disorders in Pregnancy
Anemia is the most common maternal problem during pregnancy. Anemia is a variation in hemoglobin concentration.
Pregnant woman will lose blood during delivery and the puerperium, and an anemic woman is at increased risk of blood transfusion and its related conditions.
During pregnancy, the blood volume increases by approximately 50% and the red blood cell mass by approximately 33%. This relatively greater increase in plasma volume results in a lower hematocrit but does not truly represent anemia.
Anemia in pregnancy most commonly results from a nutritional deficiency in either iron or folate. Pernicious anemia due to vitamin B12 deficiency almost never occurs during pregnancy. Other anemias occurring during pregnancy include anemia of chronic disease; anemia due to hemoglobinopathy; immune, or drug-induced hemolytic anemia; and aplastic anemia.
Related Conference of Hematologic Disorders in Pregnancy
Hematologic Disorders in Pregnancy Conference Speakers
Recommended Sessions
- Advanced treatment and Research in hematology
- Artificial Intelligence techniques in Hematology Oncology
- Bizarre Blood Diseases
- Blood and Blood disorders
- Blood transfusion
- Bone Marrow Transplantation
- Diagnosis, Treatment And Management Of Hematology
- Entrepreneurs Investment Meet
- Genetic Blood Disorders
- Hematologic Disorders in Pregnancy
- Hematology and Hematologists
- Hematology and Pharma industry
- Hematology Nursing
- Hematology Oncology
- Hematology Veterinary
- Hematopathology
- Pediatric Hematology
- Stem cells and Disorders
- Storage and Processing of the blood
Related Journals
Are you interested in
- Advances in Hematologic Malignancies - Blood Disorders 2025 (Italy)
- Advances in Hemostasis and Thrombosis - Blood Disorders 2025 (Italy)
- Blood Disorders and the Immune System - Blood Disorders 2025 (Italy)
- Blood Disorders Diagnosis & Treatment - HEMATOLOGY 2025 (Spain)
- Blood Disorders in Aging Populations - Blood Disorders 2025 (Italy)
- Blood Transfusion - HEMATOLOGY 2025 (Spain)
- Case reports of Hematology - HEMATOLOGY 2025 (Spain)
- CellTherapy - HEMATOLOGY 2025 (Spain)
- COVID-19 and Hematology - HEMATOLOGY 2025 (Spain)
- Cutting-Edge Research in Blood Disorders - Blood Disorders 2025 (Italy)
- Disorders of Vascular Bleeding - HEMATOLOGY 2025 (Spain)
- Future Trends in Hematology: Artificial Intelligence and Big Data - Blood Disorders 2025 (Italy)
- Gene Therapy and Genetic Engineering in Hematology - Blood Disorders 2025 (Italy)
- Hematologic Toxicities and Side Effects of Cancer Therapy - Blood Disorders 2025 (Italy)
- Hematology - HEMATOLOGY 2025 (Spain)
- Hematology in Global Health: Addressing Disparities - Blood Disorders 2025 (Italy)
- Hematology Oncology - HEMATOLOGY 2025 (Spain)
- Immunohematology - HEMATOLOGY 2025 (Spain)
- Immunotherapy and Cellular Therapies in Hematology - Blood Disorders 2025 (Italy)
- Innovations in Red Blood Cell Disorders - Blood Disorders 2025 (Italy)
- Leukaemia and Lymphoma - HEMATOLOGY 2025 (Spain)
- Multiple Myeloma, Amyloidosis, and Stem Cell Transplantation - HEMATOLOGY 2025 (Spain)
- New Drug Development in Hematology - HEMATOLOGY 2025 (Spain)
- Novel Diagnostic Techniques and Biomarkers in Hematology - Blood Disorders 2025 (Italy)
- Patient Blood Management - HEMATOLOGY 2025 (Spain)
- Pediatric Hematology - HEMATOLOGY 2025 (Spain)
- Pediatric Hematology: Challenges and Innovations - Blood Disorders 2025 (Italy)
- Stem Cell Research - HEMATOLOGY 2025 (Spain)
- Stem Cell Transplantation and Regenerative Medicine - Blood Disorders 2025 (Italy)
- Thalassemia - HEMATOLOGY 2025 (Spain)
- Therapeutic Apheresis - HEMATOLOGY 2025 (Spain)
- Thrombosis and Coagulation - HEMATOLOGY 2025 (Spain)
- Transfusion Medicine - HEMATOLOGY 2025 (Spain)
- Transfusion Medicine: Advances and Challenge - Blood Disorders 2025 (Italy)
- Transfusion Transmissible Infections - HEMATOLOGY 2025 (Spain)